Company / R&D per Share
NEUROONE MEDICAL TECHNOLOGIES Corp R&D per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.16
FY2025
5-year range
$0.16 / $0.33
FY2021-FY2025
Trend
-43.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has declined for 3 consecutive years, from $0.33 in FY2022 to $0.16 in FY2025.
Based on SEC 10-K filings.
0.16 in FY2025 with a 3-year CAGR of -20.5%.
Declined from $0.30 to $0.16 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -20.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- NEUROONE MEDICAL TECHNOLOGIES Corp's r&d per share has declined for 3 consecutive years.
- In FY2025, r&d per share decreased 43.3% year-over-year.
- Peak r&d per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.16 | -43.3% |
| FY2024 | $0.29 | -4.6% |
| FY2023 | $0.30 | -7.0% |
| FY2022 | $0.33 | +16.4% |
| FY2021 | $0.28 | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026